Structure

Physi-Chem Properties

Molecular Weight:  244.07
Volume:  244.373
LogP:  3.019
LogD:  3.003
LogS:  -3.269
# Rotatable Bonds:  0
TPSA:  59.67
# H-Bond Aceptor:  4
# H-Bond Donor:  1
# Rings:  3
# Heavy Atoms:  4

MedChem Properties

QED Drug-Likeness Score:  0.724
Synthetic Accessibility Score:  2.906
Fsp3:  0.214
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.704
MDCK Permeability:  2.0426188712008297e-05
Pgp-inhibitor:  0.189
Pgp-substrate:  0.002
Human Intestinal Absorption (HIA):  0.01
20% Bioavailability (F20%):  0.009
30% Bioavailability (F30%):  0.577

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.029
Plasma Protein Binding (PPB):  96.32157135009766%
Volume Distribution (VD):  0.548
Pgp-substrate:  6.773091793060303%

ADMET: Metabolism

CYP1A2-inhibitor:  0.976
CYP1A2-substrate:  0.803
CYP2C19-inhibitor:  0.337
CYP2C19-substrate:  0.168
CYP2C9-inhibitor:  0.35
CYP2C9-substrate:  0.875
CYP2D6-inhibitor:  0.855
CYP2D6-substrate:  0.59
CYP3A4-inhibitor:  0.69
CYP3A4-substrate:  0.231

ADMET: Excretion

Clearance (CL):  7.741
Half-life (T1/2):  0.477

ADMET: Toxicity

hERG Blockers:  0.041
Human Hepatotoxicity (H-HT):  0.826
Drug-inuced Liver Injury (DILI):  0.857
AMES Toxicity:  0.043
Rat Oral Acute Toxicity:  0.632
Maximum Recommended Daily Dose:  0.7
Skin Sensitization:  0.64
Carcinogencity:  0.854
Eye Corrosion:  0.007
Eye Irritation:  0.536
Respiratory Toxicity:  0.527

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC230157

Natural Product ID:  NPC230157
Common Name*:   Cedrecoumarin A
IUPAC Name:   5-hydroxy-3,3-dimethylpyrano[3,2-f]chromen-8-one
Synonyms:  
Standard InCHIKey:  OGTYTYOKQRCQEM-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C14H12O4/c1-14(2)6-5-9-8-3-4-12(16)17-11(8)7-10(15)13(9)18-14/h3-7,15H,1-2H3
SMILES:  CC1(C)C=Cc2c3ccc(=O)oc3cc(c2O1)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL491519
PubChem CID:   10263845
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000145] Coumarins and derivatives
        • [CHEMONTID:0003484] Pyranocoumarins
          • [CHEMONTID:0003485] Angular pyranocoumarins

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO32494 cedrelopsis microfoliata Species Rutaceae Eukaryota n.a. n.a. n.a. PMID[12350164]
NPO19319 Cedrelopsis grevei Species Rutaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO19319 Cedrelopsis grevei Species Rutaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO19319 Cedrelopsis grevei Species Rutaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT108 Individual Protein Estrogen receptor alpha Homo sapiens Activity = 20.0 % PMID[497108]
NPT248 Individual Protein Estrogen receptor beta Homo sapiens Activity = 20.0 % PMID[497108]
NPT2 Others Unspecified IC50 = 13.0 ug.mL-1 PMID[497108]
NPT2 Others Unspecified IC50 = 0.2 ug.mL-1 PMID[497108]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC230157 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9424 High Similarity NPC236419
0.9412 High Similarity NPC82271
0.9412 High Similarity NPC126682
0.9343 High Similarity NPC148835
0.9343 High Similarity NPC95162
0.9343 High Similarity NPC76336
0.9343 High Similarity NPC20511
0.9343 High Similarity NPC52086
0.9343 High Similarity NPC139548
0.9275 High Similarity NPC13067
0.9191 High Similarity NPC26673
0.9191 High Similarity NPC277021
0.9149 High Similarity NPC34245
0.9149 High Similarity NPC6568
0.9149 High Similarity NPC91492
0.9149 High Similarity NPC256555
0.9149 High Similarity NPC7439
0.9149 High Similarity NPC110067
0.9124 High Similarity NPC92830
0.9118 High Similarity NPC137949
0.9065 High Similarity NPC38874
0.9044 High Similarity NPC73738
0.9028 High Similarity NPC178129
0.9028 High Similarity NPC231149
0.8966 High Similarity NPC139839
0.8951 High Similarity NPC185127
0.8929 High Similarity NPC105493
0.8904 High Similarity NPC30688
0.8904 High Similarity NPC176903
0.8897 High Similarity NPC27239
0.8897 High Similarity NPC123127
0.8873 High Similarity NPC300611
0.8865 High Similarity NPC164148
0.8865 High Similarity NPC43500
0.8857 High Similarity NPC167517
0.8844 High Similarity NPC294522
0.8844 High Similarity NPC205727
0.8844 High Similarity NPC120426
0.8844 High Similarity NPC21184
0.8836 High Similarity NPC48366
0.8832 High Similarity NPC240722
0.8832 High Similarity NPC244799
0.8819 High Similarity NPC471763
0.8794 High Similarity NPC474886
0.8777 High Similarity NPC474810
0.8767 High Similarity NPC476347
0.8732 High Similarity NPC270256
0.8725 High Similarity NPC163598
0.8725 High Similarity NPC264875
0.8725 High Similarity NPC120774
0.8714 High Similarity NPC309953
0.8707 High Similarity NPC187398
0.8707 High Similarity NPC476348
0.8705 High Similarity NPC137669
0.8699 High Similarity NPC205361
0.8662 High Similarity NPC476171
0.8658 High Similarity NPC213197
0.8652 High Similarity NPC472521
0.8652 High Similarity NPC234865
0.8649 High Similarity NPC313334
0.8649 High Similarity NPC206264
0.8649 High Similarity NPC212670
0.8643 High Similarity NPC241341
0.8643 High Similarity NPC233018
0.8643 High Similarity NPC36437
0.8639 High Similarity NPC275125
0.8639 High Similarity NPC15577
0.8639 High Similarity NPC97937
0.8639 High Similarity NPC170239
0.8633 High Similarity NPC142530
0.8633 High Similarity NPC147317
0.863 High Similarity NPC476450
0.8621 High Similarity NPC138212
0.8611 High Similarity NPC279851
0.8611 High Similarity NPC472520
0.8592 High Similarity NPC286843
0.8592 High Similarity NPC309031
0.8582 High Similarity NPC147030
0.8582 High Similarity NPC111635
0.8571 High Similarity NPC319969
0.8571 High Similarity NPC123954
0.8571 High Similarity NPC474635
0.8571 High Similarity NPC475896
0.8552 High Similarity NPC469564
0.8531 High Similarity NPC276328
0.8523 High Similarity NPC113790
0.8521 High Similarity NPC240915
0.8521 High Similarity NPC252095
0.8514 High Similarity NPC41844
0.8503 High Similarity NPC125617
0.8503 High Similarity NPC292256
0.8467 Intermediate Similarity NPC300326
0.8467 Intermediate Similarity NPC58279
0.8456 Intermediate Similarity NPC248786
0.8456 Intermediate Similarity NPC96294
0.8451 Intermediate Similarity NPC106215
0.8451 Intermediate Similarity NPC474600
0.844 Intermediate Similarity NPC245120
0.8429 Intermediate Similarity NPC19242
0.8421 Intermediate Similarity NPC149735
0.8417 Intermediate Similarity NPC474616
0.8417 Intermediate Similarity NPC109275
0.8414 Intermediate Similarity NPC144284
0.8403 Intermediate Similarity NPC225106
0.8403 Intermediate Similarity NPC294456
0.8403 Intermediate Similarity NPC20796
0.8403 Intermediate Similarity NPC212124
0.8403 Intermediate Similarity NPC281014
0.8403 Intermediate Similarity NPC184861
0.8392 Intermediate Similarity NPC73071
0.8389 Intermediate Similarity NPC137352
0.8389 Intermediate Similarity NPC183083
0.838 Intermediate Similarity NPC105554
0.838 Intermediate Similarity NPC168059
0.838 Intermediate Similarity NPC229442
0.838 Intermediate Similarity NPC472522
0.8369 Intermediate Similarity NPC469907
0.8366 Intermediate Similarity NPC473736
0.8357 Intermediate Similarity NPC48315
0.8357 Intermediate Similarity NPC45824
0.8345 Intermediate Similarity NPC127218
0.8345 Intermediate Similarity NPC245207
0.8345 Intermediate Similarity NPC319647
0.8345 Intermediate Similarity NPC25966
0.8344 Intermediate Similarity NPC470916
0.8344 Intermediate Similarity NPC114740
0.8333 Intermediate Similarity NPC78746
0.8333 Intermediate Similarity NPC188380
0.8333 Intermediate Similarity NPC301089
0.8333 Intermediate Similarity NPC224543
0.8333 Intermediate Similarity NPC155101
0.8323 Intermediate Similarity NPC247713
0.8322 Intermediate Similarity NPC268515
0.8322 Intermediate Similarity NPC7163
0.8322 Intermediate Similarity NPC40222
0.8322 Intermediate Similarity NPC287275
0.8311 Intermediate Similarity NPC50250
0.831 Intermediate Similarity NPC86655
0.831 Intermediate Similarity NPC202762
0.8309 Intermediate Similarity NPC52247
0.8309 Intermediate Similarity NPC187868
0.8301 Intermediate Similarity NPC475141
0.8301 Intermediate Similarity NPC150442
0.8298 Intermediate Similarity NPC214860
0.8298 Intermediate Similarity NPC474617
0.8298 Intermediate Similarity NPC91291
0.8291 Intermediate Similarity NPC67959
0.8288 Intermediate Similarity NPC234568
0.8286 Intermediate Similarity NPC46274
0.8286 Intermediate Similarity NPC226331
0.8278 Intermediate Similarity NPC474393
0.8278 Intermediate Similarity NPC474347
0.8278 Intermediate Similarity NPC10010
0.8276 Intermediate Similarity NPC153818
0.8276 Intermediate Similarity NPC102904
0.8276 Intermediate Similarity NPC232246
0.8276 Intermediate Similarity NPC35550
0.8276 Intermediate Similarity NPC276490
0.8276 Intermediate Similarity NPC126206
0.8276 Intermediate Similarity NPC326797
0.8276 Intermediate Similarity NPC176051
0.8276 Intermediate Similarity NPC103976
0.8276 Intermediate Similarity NPC474282
0.8276 Intermediate Similarity NPC107551
0.8273 Intermediate Similarity NPC476006
0.8269 Intermediate Similarity NPC37502
0.8269 Intermediate Similarity NPC474290
0.8269 Intermediate Similarity NPC267627
0.8269 Intermediate Similarity NPC238381
0.8269 Intermediate Similarity NPC40702
0.8264 Intermediate Similarity NPC472337
0.8264 Intermediate Similarity NPC472525
0.8264 Intermediate Similarity NPC327382
0.8264 Intermediate Similarity NPC33986
0.8261 Intermediate Similarity NPC183446
0.8255 Intermediate Similarity NPC86069
0.8252 Intermediate Similarity NPC36661
0.8247 Intermediate Similarity NPC8712
0.8247 Intermediate Similarity NPC62903
0.8247 Intermediate Similarity NPC268484
0.8247 Intermediate Similarity NPC178134
0.8247 Intermediate Similarity NPC7178
0.8239 Intermediate Similarity NPC82503
0.8239 Intermediate Similarity NPC66430
0.8239 Intermediate Similarity NPC85057
0.8239 Intermediate Similarity NPC37009
0.8239 Intermediate Similarity NPC130920
0.8235 Intermediate Similarity NPC169404
0.8235 Intermediate Similarity NPC302107
0.8235 Intermediate Similarity NPC53587
0.8235 Intermediate Similarity NPC307253
0.8235 Intermediate Similarity NPC176186
0.8231 Intermediate Similarity NPC195357
0.8231 Intermediate Similarity NPC83375
0.8231 Intermediate Similarity NPC152771
0.8231 Intermediate Similarity NPC224876
0.8231 Intermediate Similarity NPC471389
0.8228 Intermediate Similarity NPC8300
0.8227 Intermediate Similarity NPC58164
0.8227 Intermediate Similarity NPC10225

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC230157 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8649 High Similarity NPD1653 Approved
0.8309 Intermediate Similarity NPD422 Phase 1
0.8286 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.8247 Intermediate Similarity NPD1465 Phase 2
0.8214 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.8056 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.8056 Intermediate Similarity NPD1613 Approved
0.8013 Intermediate Similarity NPD2801 Approved
0.7895 Intermediate Similarity NPD1511 Approved
0.7866 Intermediate Similarity NPD5844 Phase 1
0.7815 Intermediate Similarity NPD3750 Approved
0.7792 Intermediate Similarity NPD1940 Clinical (unspecified phase)
0.7792 Intermediate Similarity NPD1512 Approved
0.7748 Intermediate Similarity NPD1652 Phase 2
0.7724 Intermediate Similarity NPD3027 Phase 3
0.7722 Intermediate Similarity NPD1934 Approved
0.7688 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7682 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7679 Intermediate Similarity NPD7549 Discontinued
0.7635 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7635 Intermediate Similarity NPD5124 Phase 1
0.7635 Intermediate Similarity NPD447 Suspended
0.7625 Intermediate Similarity NPD3817 Phase 2
0.7582 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7517 Intermediate Similarity NPD230 Phase 1
0.75 Intermediate Similarity NPD1548 Phase 1
0.7485 Intermediate Similarity NPD6234 Discontinued
0.7483 Intermediate Similarity NPD4625 Phase 3
0.7483 Intermediate Similarity NPD3748 Approved
0.7471 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7469 Intermediate Similarity NPD3882 Suspended
0.7455 Intermediate Similarity NPD6232 Discontinued
0.7453 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.745 Intermediate Similarity NPD4060 Phase 1
0.7431 Intermediate Similarity NPD4749 Approved
0.7415 Intermediate Similarity NPD1008 Clinical (unspecified phase)
0.7413 Intermediate Similarity NPD1610 Phase 2
0.7407 Intermediate Similarity NPD5402 Approved
0.7394 Intermediate Similarity NPD7199 Phase 2
0.7381 Intermediate Similarity NPD3818 Discontinued
0.7379 Intermediate Similarity NPD3225 Approved
0.7372 Intermediate Similarity NPD228 Approved
0.7343 Intermediate Similarity NPD3496 Discontinued
0.7337 Intermediate Similarity NPD7054 Approved
0.7321 Intermediate Similarity NPD7473 Discontinued
0.731 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7305 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7297 Intermediate Similarity NPD4908 Phase 1
0.7294 Intermediate Similarity NPD7472 Approved
0.7292 Intermediate Similarity NPD1611 Approved
0.7284 Intermediate Similarity NPD37 Approved
0.7273 Intermediate Similarity NPD7266 Discontinued
0.7262 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7262 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7262 Intermediate Similarity NPD6166 Phase 2
0.7256 Intermediate Similarity NPD4966 Approved
0.7256 Intermediate Similarity NPD4967 Phase 2
0.7256 Intermediate Similarity NPD4965 Approved
0.7239 Intermediate Similarity NPD7819 Suspended
0.7212 Intermediate Similarity NPD3749 Approved
0.7211 Intermediate Similarity NPD2797 Approved
0.72 Intermediate Similarity NPD1296 Phase 2
0.72 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.72 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7197 Intermediate Similarity NPD6190 Approved
0.7193 Intermediate Similarity NPD7074 Phase 3
0.7176 Intermediate Similarity NPD7228 Approved
0.7169 Intermediate Similarity NPD919 Approved
0.7163 Intermediate Similarity NPD6671 Approved
0.7153 Intermediate Similarity NPD4626 Approved
0.7151 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7151 Intermediate Similarity NPD6797 Phase 2
0.7143 Intermediate Similarity NPD6696 Suspended
0.7133 Intermediate Similarity NPD7095 Approved
0.7126 Intermediate Similarity NPD5494 Approved
0.7125 Intermediate Similarity NPD7314 Clinical (unspecified phase)
0.7114 Intermediate Similarity NPD3018 Phase 2
0.7114 Intermediate Similarity NPD2861 Phase 2
0.711 Intermediate Similarity NPD7251 Discontinued
0.7108 Intermediate Similarity NPD7075 Discontinued
0.7107 Intermediate Similarity NPD6799 Approved
0.7105 Intermediate Similarity NPD1558 Phase 1
0.7097 Intermediate Similarity NPD2935 Discontinued
0.7097 Intermediate Similarity NPD6100 Approved
0.7097 Intermediate Similarity NPD1551 Phase 2
0.7097 Intermediate Similarity NPD6099 Approved
0.7086 Intermediate Similarity NPD3268 Approved
0.7086 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7081 Intermediate Similarity NPD5403 Approved
0.7076 Intermediate Similarity NPD3751 Discontinued
0.7073 Intermediate Similarity NPD6801 Discontinued
0.7069 Intermediate Similarity NPD7808 Phase 3
0.7063 Intermediate Similarity NPD5401 Approved
0.7063 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7059 Intermediate Similarity NPD9697 Approved
0.7055 Intermediate Similarity NPD3705 Approved
0.7045 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7032 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7032 Intermediate Similarity NPD1510 Phase 2
0.7032 Intermediate Similarity NPD4308 Phase 3
0.703 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7022 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7007 Intermediate Similarity NPD9269 Phase 2
0.7007 Intermediate Similarity NPD9717 Approved
0.7006 Intermediate Similarity NPD1549 Phase 2
0.7006 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.6994 Remote Similarity NPD3226 Approved
0.6988 Remote Similarity NPD4288 Approved
0.6982 Remote Similarity NPD8127 Discontinued
0.6982 Remote Similarity NPD1247 Approved
0.698 Remote Similarity NPD1203 Approved
0.6975 Remote Similarity NPD6980 Clinical (unspecified phase)
0.6966 Remote Similarity NPD5691 Approved
0.6962 Remote Similarity NPD6674 Discontinued
0.6959 Remote Similarity NPD2982 Phase 2
0.6959 Remote Similarity NPD2983 Phase 2
0.6957 Remote Similarity NPD2533 Approved
0.6957 Remote Similarity NPD2532 Approved
0.6957 Remote Similarity NPD7410 Clinical (unspecified phase)
0.6957 Remote Similarity NPD2534 Approved
0.6951 Remote Similarity NPD6599 Discontinued
0.6951 Remote Similarity NPD4380 Phase 2
0.6948 Remote Similarity NPD4340 Discontinued
0.6946 Remote Similarity NPD7768 Phase 2
0.6943 Remote Similarity NPD1550 Clinical (unspecified phase)
0.6943 Remote Similarity NPD1552 Clinical (unspecified phase)
0.6943 Remote Similarity NPD5762 Approved
0.6943 Remote Similarity NPD5763 Approved
0.6939 Remote Similarity NPD1535 Discovery
0.6939 Remote Similarity NPD1091 Approved
0.6928 Remote Similarity NPD6233 Phase 2
0.6918 Remote Similarity NPD1878 Clinical (unspecified phase)
0.6918 Remote Similarity NPD4628 Phase 3
0.6909 Remote Similarity NPD5090 Approved
0.6909 Remote Similarity NPD5089 Approved
0.6901 Remote Similarity NPD1398 Phase 1
0.6894 Remote Similarity NPD4357 Discontinued
0.6892 Remote Similarity NPD1608 Approved
0.6892 Remote Similarity NPD1481 Phase 2
0.6892 Remote Similarity NPD2981 Phase 2
0.6887 Remote Similarity NPD9494 Approved
0.6883 Remote Similarity NPD1240 Approved
0.6883 Remote Similarity NPD943 Approved
0.6871 Remote Similarity NPD920 Approved
0.6867 Remote Similarity NPD3266 Approved
0.6867 Remote Similarity NPD3267 Approved
0.6863 Remote Similarity NPD1699 Clinical (unspecified phase)
0.6863 Remote Similarity NPD411 Approved
0.6863 Remote Similarity NPD7985 Registered
0.6863 Remote Similarity NPD3764 Approved
0.6855 Remote Similarity NPD5698 Clinical (unspecified phase)
0.6855 Remote Similarity NPD1243 Approved
0.6842 Remote Similarity NPD3787 Discontinued
0.6839 Remote Similarity NPD1933 Approved
0.6835 Remote Similarity NPD1358 Approved
0.6835 Remote Similarity NPD2346 Discontinued
0.6831 Remote Similarity NPD5535 Approved
0.6829 Remote Similarity NPD3686 Approved
0.6829 Remote Similarity NPD3687 Approved
0.6828 Remote Similarity NPD5536 Phase 2
0.6828 Remote Similarity NPD7644 Approved
0.6818 Remote Similarity NPD6559 Discontinued
0.6818 Remote Similarity NPD7685 Pre-registration
0.6807 Remote Similarity NPD7411 Suspended
0.6803 Remote Similarity NPD1778 Approved
0.6795 Remote Similarity NPD1607 Approved
0.6784 Remote Similarity NPD6959 Discontinued
0.6783 Remote Similarity NPD5283 Phase 1
0.6778 Remote Similarity NPD6841 Approved
0.6778 Remote Similarity NPD6843 Phase 3
0.6778 Remote Similarity NPD6842 Approved
0.6774 Remote Similarity NPD3620 Phase 2
0.6774 Remote Similarity NPD4307 Phase 2
0.6774 Remote Similarity NPD3619 Clinical (unspecified phase)
0.6774 Remote Similarity NPD4140 Approved
0.6772 Remote Similarity NPD2796 Approved
0.6759 Remote Similarity NPD7340 Approved
0.6755 Remote Similarity NPD987 Approved
0.6753 Remote Similarity NPD6798 Discontinued
0.675 Remote Similarity NPD2800 Approved
0.675 Remote Similarity NPD7421 Clinical (unspecified phase)
0.6744 Remote Similarity NPD7229 Phase 3
0.6735 Remote Similarity NPD9268 Approved
0.6731 Remote Similarity NPD6355 Discontinued
0.673 Remote Similarity NPD1375 Discontinued
0.6725 Remote Similarity NPD5677 Discontinued
0.6723 Remote Similarity NPD7240 Approved
0.6714 Remote Similarity NPD290 Approved
0.6711 Remote Similarity NPD6917 Clinical (unspecified phase)
0.6709 Remote Similarity NPD7033 Discontinued
0.6708 Remote Similarity NPD4110 Phase 3
0.6708 Remote Similarity NPD4109 Clinical (unspecified phase)
0.6708 Remote Similarity NPD7982 Clinical (unspecified phase)
0.6708 Remote Similarity NPD8166 Discontinued
0.6707 Remote Similarity NPD3647 Clinical (unspecified phase)
0.6704 Remote Similarity NPD7090 Clinical (unspecified phase)
0.6704 Remote Similarity NPD8053 Approved
0.6704 Remote Similarity NPD8054 Approved
0.6689 Remote Similarity NPD8651 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data